Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dihydrochloride, Pirenzepine
2. Gastrotsepin
3. Gastrozepin
4. L-s 519
5. Ls 519
6. Ls-519
7. Ls519
8. Piren Basan
9. Piren-basan
10. Pirenzepin
11. Pirenzepin Ratiopharm
12. Pirenzepin Von Ct
13. Pirenzepin-ratiopharm
14. Pirenzepine Dihydrochloride
15. Pyrenzepine
16. Ulcoprotect
17. Ulgescum
18. Von Ct, Pirenzepin
1. 28797-61-7
2. Pirenzepinum
3. Pirenzepina
4. Pirenzepin
5. 11-[2-(4-methylpiperazin-1-yl)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one
6. Pirenzepine (inn)
7. 11-((4-methyl-1-piperazinyl)acetyl)-5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one
8. 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one
9. Chembl9967
10. 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one
11. 6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-
12. Aci-91
13. Chebi:8247
14. Pirenzepinedihydrochloridemonohydrate
15. 3g0285n20n
16. Ncgc00015836-08
17. Pirenzepinum [inn-latin]
18. Pirenzepina [inn-spanish]
19. Pirenzepine [inn]
20. Dsstox_cid_3487
21. Pirenzepine [inn:ban]
22. Dsstox_rid_77049
23. Dsstox_gsid_23487
24. Mls000069702
25. 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one
26. 6h-pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-
27. 6h-pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- (8ci,9ci)
28. 6h-pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-
29. Cas-28797-61-7
30. Smr000058502
31. Einecs 249-228-4
32. Ls-519
33. Brn 0628987
34. Unii-3g0285n20n
35. Pirenzepine-[d8]
36. Spectrum_001378
37. Tocris-1071
38. Starbld0016668
39. Pirenzepine [mi]
40. Prestwick0_000129
41. Prestwick1_000129
42. Prestwick2_000129
43. Prestwick3_000129
44. Spectrum2_001417
45. Spectrum3_001453
46. Spectrum4_000437
47. Spectrum5_001344
48. Lopac-p-7412
49. Pirenzepine [vandf]
50. Lopac0_000962
51. Schembl41705
52. Bspbio_000178
53. Bspbio_002945
54. Gtpl328
55. Kbiogr_000794
56. Kbioss_001858
57. Pirenzepine [who-dd]
58. Divk1c_000127
59. Spbio_001494
60. Spbio_002117
61. Bpbio1_000196
62. Cid_185248
63. Dtxsid7023487
64. Bdbm39341
65. Kbio1_000127
66. Kbio2_001858
67. Kbio2_004426
68. Kbio2_006994
69. Kbio3_002445
70. Ninds_000127
71. Hms2089k21
72. Hms3742e07
73. Hms3742g13
74. Bcp12188
75. Tox21_110239
76. Hy-17037a
77. Pdsp1_000965
78. Pdsp2_000949
79. Zinc19632927
80. Akos015969751
81. Tox21_110239_1
82. Ccg-205042
83. Db00670
84. Sdccgsbi-0050935.p004
85. Idi1_000127
86. Ncgc00015836-01
87. Ncgc00015836-02
88. Ncgc00015836-03
89. Ncgc00015836-04
90. Ncgc00015836-05
91. Ncgc00015836-06
92. Ncgc00015836-07
93. Ncgc00015836-09
94. Ncgc00015836-10
95. Ncgc00015836-12
96. Ncgc00015836-19
97. Ncgc00024297-02
98. Ncgc00024297-04
99. Ncgc00024297-05
100. Sbi-0050935.p003
101. Cas-29868-97-1
102. Ab00053603
103. Cs-0013749
104. Ft-0600051
105. Ft-0673943
106. 97p617
107. C07508
108. D08389
109. Ab00053603-08
110. Ab00053603_09
111. L000485
112. Q419550
113. Brd-k89375097-300-05-4
114. Brd-k89375097-300-06-2
115. 11-[2-(4-methylpiperazino)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
116. 11-[(4-methyl-1-piperazinyl)acetyl]-5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one #
117. 11-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
118. 11-[2-(4-methyl-piperazin-1-yl)-acetyl]-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one
119. 11-[2-(4-methylpiperazin-1-yl)-acetyl]-5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one
120. 11-[2-(4-methylpiperazin-1-yl)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
121. 11-[2-(4-methylpiperazin-1-yl)ethanoyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
122. 2-[2-(4-methylpiperazin-1-yl)acetyl]-2,4,9-triazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
Molecular Weight | 351.4 g/mol |
---|---|
Molecular Formula | C19H21N5O2 |
XLogP3 | 0.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 351.16952493 g/mol |
Monoisotopic Mass | 351.16952493 g/mol |
Topological Polar Surface Area | 68.8 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 534 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.
Pirenzepine belongs to a group of medications called antispasmodics/anticholinergics. These medications are used to relieve cramps or spasms of the stomach, intestines, and bladder. Pirenzepine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX03 - Pirenzepine
Pirenzepine is a muscarinic receptor antagonist and binds to the muscarinic acetylcholine receptor. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins.
ABOUT THIS PAGE
83
PharmaCompass offers a list of Pirenzepine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pirenzepine manufacturer or Pirenzepine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pirenzepine manufacturer or Pirenzepine supplier.
PharmaCompass also assists you with knowing the Pirenzepine API Price utilized in the formulation of products. Pirenzepine API Price is not always fixed or binding as the Pirenzepine Price is obtained through a variety of data sources. The Pirenzepine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gastrozepin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gastrozepin, including repackagers and relabelers. The FDA regulates Gastrozepin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gastrozepin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gastrozepin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gastrozepin supplier is an individual or a company that provides Gastrozepin active pharmaceutical ingredient (API) or Gastrozepin finished formulations upon request. The Gastrozepin suppliers may include Gastrozepin API manufacturers, exporters, distributors and traders.
click here to find a list of Gastrozepin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gastrozepin DMF (Drug Master File) is a document detailing the whole manufacturing process of Gastrozepin active pharmaceutical ingredient (API) in detail. Different forms of Gastrozepin DMFs exist exist since differing nations have different regulations, such as Gastrozepin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gastrozepin DMF submitted to regulatory agencies in the US is known as a USDMF. Gastrozepin USDMF includes data on Gastrozepin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gastrozepin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gastrozepin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Gastrozepin Drug Master File in Japan (Gastrozepin JDMF) empowers Gastrozepin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Gastrozepin JDMF during the approval evaluation for pharmaceutical products. At the time of Gastrozepin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Gastrozepin suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gastrozepin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gastrozepin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gastrozepin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gastrozepin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gastrozepin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gastrozepin suppliers with NDC on PharmaCompass.
Gastrozepin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gastrozepin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gastrozepin GMP manufacturer or Gastrozepin GMP API supplier for your needs.
A Gastrozepin CoA (Certificate of Analysis) is a formal document that attests to Gastrozepin's compliance with Gastrozepin specifications and serves as a tool for batch-level quality control.
Gastrozepin CoA mostly includes findings from lab analyses of a specific batch. For each Gastrozepin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gastrozepin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gastrozepin EP), Gastrozepin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gastrozepin USP).